{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:58:33Z","timestamp":1787752713703,"version":"build-2784847793"},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.xpro.2022.101400","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T04:10:20Z","timestamp":1652501420000},"page":"101400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Generation, expansion, and drug treatment of hematopoietic progenitor cells derived from human iPSCs"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-8854","authenticated-orcid":false,"given":"Benjamin","family":"Dannenmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Skokowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2022.101400_bib1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.stem.2021.03.023","article-title":"iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia","volume":"28","author":"Dannenmann","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2022.101400_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-1-0716-0290-4_27","article-title":"CRISPR\/Cas9 genome editing of human-induced pluripotent stem cells followed by granulocytic differentiation","volume":"2115","author":"Dannenmann","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xpro.2022.101400_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exphem.2018.12.006","article-title":"Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34(+) cells preceding leukemic transformation","volume":"71","author":"Dannenmann","year":"2019","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.xpro.2022.101400_bib4","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood.V88.10.3765.bloodjournal88103765","article-title":"Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor","volume":"88","author":"Hogge","year":"1996","journal-title":"Blood"}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166722002805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166722002805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:25:23Z","timestamp":1724977523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166722002805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2666166722002805"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2022.101400","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation, expansion, and drug treatment of hematopoietic progenitor cells derived from human iPSCs","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2022.101400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2021.03.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101400"}}